<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01171885</url>
  </required_header>
  <id_info>
    <org_study_id>CAAE-0003.0.419.419-0</org_study_id>
    <nct_id>NCT01171885</nct_id>
  </id_info>
  <brief_title>Bilateral Superficial Cervical Block for Thyroidectomy</brief_title>
  <official_title>Evaluation of the Postoperative Analgesic Efficacy of Bilateral Superficial Cervical Block for Thyroidectomy and Mini Incision Under General Balanced Anesthesia: a Randomized, Triple Masked, Placebo Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Lifecenter Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Federal University of Minas Gerais</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Lifecenter Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to compare the postoperative analgesia afforded by bilateral
      superficial cervical block using different concentrations of local anesthetic (ropivacaine)
      in patients undergoing total thyroidectomy for the mini-incision technique, performed by the
      same surgical team.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we will evaluate the efficacy of bilateral superficial cervical block
      associated with balanced general anesthesia with remifentanil as opioid of choice in
      preventing postoperative pain in patients who underwent total thyroidectomy with mini
      incision without neck dissection.A hundred and twenty patients ASA I - II will be assessed
      and allocated randomly (through a table of random numbers) into three groups for analgesia
      for post-operative:

      Group 1: bilateral superficial cervical block with 20 ml of 0.9% saline (placebo); Group 2:
      bilateral superficial cervical block with 20 ml ropivacaine 0.25%; Group 3: bilateral
      superficial cervical block with 20 ml ropivacaine 0.5%.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2009</start_date>
  <completion_date type="Anticipated">December 2011</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Post operative pain assessment according to Visual Analogue Scale</measure>
    <time_frame>24 Hours</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Consumption of morphine</measure>
    <time_frame>24 Hours</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Cervical Pain</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Bilateral superficial cervical block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine 0.25%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral superficial cervical block</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Ropivacaine 0.5%</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Bilateral superficial cervical block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>0.9% saline</intervention_name>
    <description>20 ml of 0.9% saline</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>20 ml of Ropivacaine 0.25%.</description>
    <arm_group_label>Ropivacaine 0.25%</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ropivacaine</intervention_name>
    <description>20 ml of Ropivacaine 0.5%.</description>
    <arm_group_label>Ropivacaine 0.5%</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age greater than 18 years

          -  Agreed to participate in the study and sign the consent form

          -  ASA I-II

          -  Scheduled to undergo total thyroidectomy without neck dissection under general
             balanced anesthesia.

        Exclusion Criteria:

          -  Clinical history or laboratory tests suggestive of bleeding disorder

          -  Mental or cognitive deficit in existence, which makes it impossible to understand the
             patient visual analog scale of pain or the study protocol

          -  Body mass index greater than 45

          -  History of allergy to local anesthetics

          -  Intolerance or contraindication to any medication used in the study

          -  Skin infection at the site of the blockade

          -  Patients requiring neck dissection

          -  Pregnancy

          -  Preoperative use of opioid analgesics or non-opioids, corticosteroids or anti
             inflammatory non steroidal

          -  Patient's refusal to participate in the study

          -  Need for emergency reintervention within the first 24 hours postoperatively
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlos Leonardo A Boni, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Federal University of Minas Gerais</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Carlos Leonardo A Boni, MD</last_name>
    <phone>00553191851959</phone>
    <email>leonardoboni@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Yerkes P Silva, PhD</last_name>
    <phone>00553199933384</phone>
    <email>yerkesps@uol.com.br</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Lifecenter Hospital</name>
      <address>
        <city>Belo Horizonte</city>
        <state>Minas Gerais</state>
        <zip>30110090</zip>
        <country>Brazil</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Carlos leonardo A Boni, MD</last_name>
      <phone>00553191851959</phone>
      <email>leonardoboni@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Yerkes P Silva, PhD</last_name>
      <phone>00553199933384</phone>
      <email>yerkesps@uol.com.br</email>
    </contact_backup>
    <investigator>
      <last_name>Yerkes P Silva, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Renato S Gomez, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Leonardo A Boni, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Brazil</country>
  </location_countries>
  <reference>
    <citation>Andrieu G, Amrouni H, Robin E, Carnaille B, Wattier JM, Pattou F, Vallet B, Lebuffe G. Analgesic efficacy of bilateral superficial cervical plexus block administered before thyroid surgery under general anaesthesia. Br J Anaesth. 2007 Oct;99(4):561-6. Epub 2007 Aug 6.</citation>
    <PMID>17681971</PMID>
  </reference>
  <reference>
    <citation>Herbland A, Cantini O, Reynier P, Valat P, Jougon J, Arimone Y, Janvier G. The bilateral superficial cervical plexus block with 0.75% ropivacaine administered before or after surgery does not prevent postoperative pain after total thyroidectomy. Reg Anesth Pain Med. 2006 Jan-Feb;31(1):34-9.</citation>
    <PMID>16418022</PMID>
  </reference>
  <reference>
    <citation>Eti Z, Irmak P, Gulluoglu BM, Manukyan MN, Gogus FY. Does bilateral superficial cervical plexus block decrease analgesic requirement after thyroid surgery? Anesth Analg. 2006 Apr;102(4):1174-6.</citation>
    <PMID>16551919</PMID>
  </reference>
  <reference>
    <citation>Steffen T, Warschkow R, Br√§ndle M, Tarantino I, Clerici T. Randomized controlled trial of bilateral superficial cervical plexus block versus placebo in thyroid surgery. Br J Surg. 2010 Jul;97(7):1000-6. doi: 10.1002/bjs.7077.</citation>
    <PMID>20632263</PMID>
  </reference>
  <verification_date>May 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 28, 2010</study_first_submitted>
  <study_first_submitted_qc>July 28, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 29, 2010</study_first_posted>
  <last_update_submitted>July 28, 2010</last_update_submitted>
  <last_update_submitted_qc>July 28, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 29, 2010</last_update_posted>
  <responsible_party>
    <name_title>Carlos Leonardo Alves Boni</name_title>
    <organization>Lifecenter Hospital</organization>
  </responsible_party>
  <keyword>Superficial cervical block</keyword>
  <keyword>Thyroidectomy</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neck Pain</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ropivacaine</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>January 9, 2012</submitted>
    <returned>February 8, 2012</returned>
    <submitted>February 15, 2013</submitted>
    <returned>March 20, 2013</returned>
    <submitted>July 28, 2014</submitted>
    <returned>August 14, 2014</returned>
    <submitted>August 31, 2015</submitted>
    <returned>September 30, 2015</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

